16.03.2015 Alphaform AG  DE0005487953

DGAP-Adhoc: Alphaform AG: resolves on capital increase from authorised capital with pre-emption rights disapplied


 
Alphaform AG / Key word(s): Capital Increase 16.03.2015 08:19 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad-hoc release Alphaform AG/Capital Increase Alphaform AG resolves on capital increase from authorised capital with pre-emption rights disapplied Placement price of EUR 2,60 Feldkirchen, 16 March 2015 - The Management Board of Europe's leading industrial 3D printing service provider Alphaform AG, with the approval of the Supervisory Board and based on authorised capital under the Articles of Association, today resolved to increase the share capital in exchange for cash contributions. The increase is of EUR 417,441.00 from EUR 7,485,387.00 to EUR 7,902,828.00 and is to be implemented by issuing up to 417,441 no-par value bearer shares at a notional value of EUR 1.00 per share with a profit-sharing entitlement from 1 January 2014. Shareholders' pre-emptive subscription rights will be disapplied. The new shares will be subscribed for by Oddo Seydler Bank AG, Frankfurt, at an issue price of EUR 1.00 and with an obligation to offer the shares to institutional investors in a private placement at a placement price of EUR 2,60. Assuming full placement, the company will receive a total of approximately EUR 1,1 million less commission and costs. The new shares are to be admitted to trading on the stock exchange without a listing prospectus and included in the existing listing in the Prime Standard segment of the regulated market on the Frankfurt stock exchange. --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: About Alphaform Founded in 1996 and headquartered in Feldkirchen near Munich, Alphaform AG is a leading European handler for the renovation of industrial development and production with innovative 3D printing and rapid technologies. As a service provider, Alphaform guides its clients from product development through to product manufacture; it assists them in introducing and utilising innovations and delivers expertise, engineering knowledge, prototypes, individual parts, small-scale series, series and project management. Among others, Alphaform today serves the premium manufacturers of the automotive industry, mechanical, plant and automotive engineering, the aerospace industry, tool making and medical technology. Its particular areas of expertise include complex assembly, lightweight construction and orthopaedic implants and instruments. It has subsidiaries in Germany, Finland, Sweden and the UK. Alphaform's shares are listed in the Prime Standard segment of the Frankfurt stock exchange (code: ATF; securities code number (WKN): 548 795). Contact: Dr. Hanns-Dieter Aberle, CEO Thomas Kresser, CFO ALPHAFORM AG ALPHAFORM AG Kapellenstraße 10 Kapellenstraße 10 85622 Feldkirchen 85622 Feldkirchen Tel.: +49 89 905002 35 Tel.: +49 89 905002 35 Fax: +49 89 905002 1035 Fax: +49 89 905002 1035 e-mail: [email protected] e-mail: [email protected] Internet: www.alphaform.de Internet: www.alphaform.de Disclaimer This press release/ad-hoc disclosure is not an offer document and does not constitute an offer of shares of Alphaform AG ('Company') nor an invitation to an offer to buy or subscribe for shares or securities of the Company but is provided for information only. This press release/ad-hoc disclosure may contain forward-looking statements that are subject to risks and uncertainties, including those pertaining to the anticipated benefits to be realized from the proposals described herein. Forward-looking statements may include, in particular, statements about future events, future financial performance, plans, strategies, expectations, prospects, competitive environment, regulation and supply and demand. The Company has based these forward-looking statements on its views and assumptions with respect to future events and financial performance. Actual financial performance could differ materially from that projected in the forward-looking statements due to the inherent uncertainty of estimates, forecasts and projections, and financial performance may be better or worse than anticipated. Given these uncertainties, persons should not put undue reliance on any forward-looking statements. The information contained in this presentation is subject to change without notice and the Company does not undertake any duty to update the forward-looking statements, and the estimates and assumptions associated with them, except to the extent required by applicable laws and regulations. Important notice to persons in the United States of America All information in this press release/ad-hoc disclosure is being made available in the United States of America only to persons believed by the Company to be capable of understanding and evaluating the risks of a transaction. No shares or other securities of the Company have been registered or otherwise qualify for a public sale or resale under federal or state laws in the United States of America. Each recipient of information doing business in or organized under any federal or state laws in the United States of America or in areas subject to its jurisdiction represents that it is an 'accredited investor' as defined by Rule 501 or Regulation D under the Securities Act of 1993 ('the Act') and acknowledges that none of the shares in the Company will be registered under the Act and cannot be resold in the absence of such registration or the availability of an exemption there from. The shares in the Company have not been approved or disapproved by the United States Securities and Exchange Commission, any state securities commission or other regulatory authority, nor have any of these authorities passed judgment upon or endorsed the merits of an investment in the shares of the Company or the accuracy or adequacy of this presentation. Any representation to the contrary is a criminal offence. Important notice to persons in the United Kingdom All information in this press release/ad-hoc disclosure is being made available to the recipients on the basis that they are persons covered by Article 11(3) of the Financial Services Act 1986 (Investment Advertisements) (Exemptions) Order 1996. By accepting this document the recipient warrants and represents that he or it is such a person. 16.03.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Alphaform AG Kapellenstraße 10 85622 Feldkirchen Germany Phone: +49 (0)89 905002 - 0 Fax: +49 (0)89 905002 - 90 E-mail: [email protected] Internet: www.alphaform.de ISIN: DE0005487953 WKN: 548795 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA1,2 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA-Marge3 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT1,4 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT-Marge5 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Jahresüberschuss1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Netto-Marge6 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Cashflow1,7 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Ergebnis je Aktie8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer:

INVESTOR-INFORMATIONEN
©boersengefluester.de
WKN Kurs in € Einschätzung Börsenwert in Mio. €
0,000 0,00
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
0,00 0,00 0,00 0,00
KBV KCV KUV EV/EBITDA
0,00 0,00 0,00 0,00
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
0,00% 0,00% 0,00% 0,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Alphaform AG  ISIN: DE0005487953 können Sie bei EQS abrufen


Kunststoffe , 548795